बायोफार्मा मिशन

National Biopharma Mission The National Biopharma Mission was formally launched by Hon’ble Minister for Science & Technology on 30th June, 2017 and the legal agreement with World Bank for flexible inancing arrangements for this Mission of DBT was executed on April 24, 2018. The Mission aims to make India a hub for design and development of novel, affordable and effective biopharmaceutical products for combating public health concerns.It would strengthen translational capability of academic researchers; empower bio-entrepreneurs and SMEs by decreasing the cost and risk during early stages of product development and also elevate the innovation quotient of the industry. The global experience of World Bank would be instrumental in building sustained global linkages, technical assistance and knowledge flow between public private partners for business promotion in biotech sector To initiate the Mission activities a dedicated Project Management Unit (PMU) at BIRAC has been established, there have been constitution of the Inter-Ministerial Steering Committee (SC) comprising of members from various Ministries; and the Program Technical Advisory Group (TAG) comprising of global and national leaders from industry and academia, to provide oversight to the National Biopharma Mission.

First round of Request for Applications (RFAs) soliciting proposals from academia and industry focusing on development of

  • Vaccines for Pneumococcus, Dengue, HPV and candidates for other diseases of high burden in India
  • Biosimilars for cancer, diabetics and rheumatoid arthritis and
  • Medical devices and diagnostics
  • Process Development Laboratory; Chemistry, Manufacturing, Control Units and cGLP

Bio-Pharma

validation facility for Bio therapeutics. Further to train the next generation of clinician-scientists and health professionals involved in clinical research, National Biopharma Mission organized a course on the “Principles and Practice of Clinical Research’, in April at Hyderabad, jointly with NIH-USA under the aegis of Indo-US VAP of DBT. Under the first published RFPs in November 124 proposals were received of which 17 proposals were finally recommended for receiving financial support

Bio-Pharma
Bio-Pharma
Bio-Pharma
Bio-Pharma

It is envisaged that this programme will help deliver 6-10 new products in the next five years, create several dedicated facilities for next-generation skills, and hundreds of jobs in the process.